Patient and public safety is not negotiable.
At a medical symposium in Copenhagen, an Indonesian researcher presented fabricated data under multiple false identities, exposing a quiet but consequential fracture in the architecture of scientific trust. The deception — discovered by fellow Indonesians who recognized the unfamiliar names — was driven not by ideology but by institutional pressure: publication counts and international travel grants had become the currency of academic worth. What unraveled in Denmark was not merely one person's misconduct, but a mirror held up to systems that reward the appearance of knowledge over its honest pursuit.
- A single presenter cycled through multiple names, outfits, and conference badges across several sessions at a major international medical symposium, fabricating entire research identities from scratch.
- The data behind the presentations was generated by artificial intelligence — no patients, no field sites, no real institutions — assembled solely to secure grants for international travel.
- Two Indonesian doctoral students, recognizing the unfamiliar names within their small research community, attended the sessions, compared notes, and methodically exposed the deception.
- The perpetrators admitted the fraud publicly via Instagram apologies, but the damage now extends to Indonesia's broader scientific reputation, with lawmakers calling for formal investigation.
- Medical experts warn that fabricated research is not an academic abstraction — it shapes clinical training, government health policy, and ultimately the care patients receive.
When the International Society of Pneumonia and Pneumococcal Diseases convened in Copenhagen last May, drawing over 1,300 researchers from 86 countries, one Indonesian presenter had prepared something unusual: multiple talks, multiple names, and data that had never touched a real patient or field site.
It was two Indonesian doctoral students — Wa Ode Dwi Daningrat, studying at Oxford, and Ida Bagus Mandhara Brasika, at Exeter — who first sensed something wrong. Indonesia's pneumonia research community is small enough that unfamiliar names stand out. Attending several sessions together, they watched the same person present under different identities, changing outfits and swapping conference badges between talks. One paper claimed fieldwork in Peru's Andean highlands with no local collaborators — nearly implausible in international research. The listed institution, the IMCDS-Biomed Research Foundation in Jakarta, did not exist. When confronted, the presenter admitted the data had been AI-generated, the scheme designed with a partner to obtain grants covering international travel. Both later posted apologies on Instagram.
The confession cracked open a larger structural question. Indonesia's academic culture has come to measure success through publication counts, conference appearances, and foreign degrees — metrics that are visible and quantifiable. Research ethics, harder to count and easier to defer, has struggled to keep pace. Education expert Ina Liem noted that once trust is broken, international institutions grow cautious toward an entire country's researchers, regardless of individual integrity.
The stakes, however, reach further than reputation. Budi Iman Santoso of the Indonesian Council of Medical Professors was direct: fabricated medical findings shape how doctors are trained, what policies governments adopt, and what treatments patients receive. False data in the medical literature is a breach of the contract between science and the public. Indonesia's House of Representatives has since called for a full investigation — and the harder question now is whether the country's academic institutions will choose to make integrity matter more than the metrics that made this deception feel worth attempting.
At a medical conference in Copenhagen last month, something unraveled that had been carefully stitched together in advance. The International Society of Pneumonia and Pneumococcal Diseases held its annual symposium from May 17 to 21, drawing more than 1,300 researchers, clinicians, and public health experts from 86 countries. Among them was an Indonesian presenter who had prepared multiple presentations, multiple identities, and data that had never been collected from any actual patient or field site.
Wa Ode Dwi Daningrat, a doctoral student at Oxford, noticed something off. She is part of a small research community—Indonesia's pneumonia researchers know each other, or at least know of each other. The names on the presentations were unfamiliar. She mentioned this to Ida Bagus Mandhara Brasika, another Indonesian doctoral student, this one at Exeter. Together they decided to attend several of the sessions. What they observed was methodical: the same presenter, introducing herself under different names, changing outfits between talks, swapping conference badges. The inconsistencies accumulated. When they dug deeper, the structure of the deception became visible.
One paper claimed research had been conducted in Peru's Andean highlands without any local collaborators—a red flag in international research, where such isolation is nearly implausible. An institution listed as the source of the work, the IMCDS-Biomed Research Foundation in Jakarta, did not exist. When confronted, the presenter admitted what had happened: the data had been generated using artificial intelligence, with help from a partner. Both the presenter, identified only as P, and the partner, identified only as RF, later posted apologies on Instagram. They had fabricated the research to secure grants that would pay for international travel.
The confession opened a wider conversation about why this had seemed worth doing. Indonesia's academic culture has developed a particular pressure: publication counts matter, international conference participation matters, degrees from abroad matter. These metrics have become the visible measure of academic success. Research ethics, by contrast, is harder to quantify and easier to defer. Ina Liem, an education expert, described the problem plainly: the academic world depends on trust, and once that trust is broken, institutions become cautious. International grant-makers and proposal reviewers may begin to view researchers from that country with suspicion, regardless of their individual integrity.
But the concern extends beyond reputation. Budi Iman Santoso, chair of the Indonesian Council of Medical Professors, emphasized that fabricated medical research carries consequences that touch actual people. Scientific findings shape how doctors are trained, what policies governments adopt, what treatments patients receive. False data in the medical literature is not a technical error in academic writing—it is a breach of the contract between researchers and the public. "Patient and public safety is not negotiable," Santoso said.
The incident has drawn the attention of Indonesia's House of Representatives. Lalu Hadrian Irfani, deputy chair of the commission overseeing education, called for a thorough investigation, warning that if the fabrication is confirmed, it could damage Indonesia's standing in the international academic community. The question now is not just what happened in Copenhagen, but what structural changes might prevent it from happening again—and whether Indonesia's academic institutions are willing to make research integrity matter more than publication counts.
Notable Quotes
Patient and public safety is not negotiable. This is not merely a technical issue in academic writing, but a serious warning about scientific integrity.— Budi Iman Santoso, Chair of the Indonesian Council of Medical Professors
The academic world relies heavily on trust. Once manipulation becomes associated with a country's academic ecosystem, international institutions may become more cautious toward researchers from that country.— Ina Liem, education expert
The Hearth Conversation Another angle on the story
Why would someone go to such elaborate lengths—multiple identities, fake institutions, AI-generated data—just to attend a conference?
The grants. International conferences are expensive. If you're in Indonesia and want to present in Copenhagen, you need money for flights, hotels, registration. The grants exist, but they're competitive. Fabricating research to secure them is a shortcut.
But wouldn't the fraud be caught immediately? These are experts in the field.
That's what makes this case interesting. It was caught, but not by the conference organizers or peer reviewers. It was caught by two other Indonesian researchers who simply knew their field well enough to notice the names didn't belong. The system failed until someone paid attention.
What does it mean that the data was AI-generated?
It means there was no fieldwork, no patients, no actual observations. The AI created plausible-sounding numbers and findings. It's not just dishonesty—it's a kind of shortcut that technology now makes possible in ways it didn't before.
Is this an Indonesian problem specifically, or a global one?
The structural pressure exists everywhere—publish or perish, chase metrics, build your CV. But Indonesia's academic culture has particular vulnerabilities. The research community is smaller, so there's less redundancy in catching fraud. And the prestige of international participation is especially high, which creates motivation.
What happens to the person who did this?
That's still unclear. They apologized publicly, admitted the fabrication. But there will likely be investigations, institutional consequences, possibly legal ones. The real question is whether this becomes a moment for systemic change or just a scandal that passes.
Could this actually harm patients?
Yes. If any of this fabricated research influenced clinical guidelines or medical education, then yes. That's why the medical professors are so alarmed. This isn't just about academic reputation—it's about trust in medical knowledge itself.